COVID-19 Myopericarditis in a Young Healthy Male

Area of Science:

• Cardiology
• Infectious Diseases
• Virology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection commonly causes pneumonia but can also affect the heart.
• Cardiac involvement in COVID-19 is linked to poorer patient outcomes.
• Myopericarditis, inflammation of the heart muscle and outer lining, is a known but less common cardiac manifestation.

Purpose of the Study:

• To report a case of myopericarditis as the primary presentation of SARS-CoV-2 infection.
• To highlight cardiac involvement in a young, healthy patient with minimal pulmonary symptoms.
• To underscore the importance of considering cardiac manifestations in COVID-19, regardless of typical respiratory symptoms.

Main Methods:

• Case report of a 20-year-old male presenting with chest pain and fever.
• Diagnostic workup included electrocardiogram (ECG), echocardiogram, and cardiac enzyme levels.
• Exclusion of other potential causes of myopericarditis.

Main Results:

• The patient exhibited ECG and echocardiogram findings consistent with myopericarditis.
• Elevated cardiac enzymes confirmed myocardial involvement.
• Other causes of myopericarditis were ruled out, implicating SARS-CoV-2.
• The patient showed a favorable recovery without long-term cardiac dysfunction.

Conclusions:

• Acute myopericarditis can be a primary manifestation of SARS-CoV-2 infection.
• Cardiac involvement in COVID-19 can occur in young, healthy individuals, potentially more frequently than previously thought.
• Further research is needed to determine the prevalence, complications, and prognostic value of cardiac involvement in COVID-19 across all age groups.